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SUMMARY 
We describe a new method for amplification, by polymerase chain reaction (PCR), of rearranged segments encoding the 
variable part of light and heavy chains of an antibody (Ab) from the chromosomal DNA of hybridoma cells for the 
chimerization ofAbs. A fundamental prerequisite for this is the knowledge ofthe exact sequences in the 5’-untranslated region 
of light and heavy chain mRNA, and of the joining segment used for rearrangement. This allows the design of nondegenerated 
oligodeoxyribonucleotides for PCR. The primer design permits directional cloning of the amplified, promoterless fragments 
into cassette vectors, in which they will be linked to the appropriate human constant domains and immunoglobulin (Ig) 
promoter/enhancer elements. The method is illustrated for chimerization of an Ab directed against the human T-lymphocyte 
antigen, CD4. The chimerized Ab is secreted in abundant quantities after transfection of the engineered plasmids into 
non-Ig-producing myeloma cells. 
INTRODUCTION 
The benefits of mAbs in the treatment of human diseases, 
such as autoimmune diseases, graft rejections and cancer 
Correspondence to: Dr. U.H. Weidle, Boehringer Mannheim GmbH, 
Abteilung fur DNS-Neukombination, Nonnenwald 2, Postfach 1152, 
D-8122 Penzberg (F.R.G.) 
Tel. (49-8856)60-2801; Fax (49-8856)8744. 
Abbreviations: aa, amino acid(s); Ab, antibody; Ap, ampicillin; bp, base 
pair(s); C, constant region; cDNA, DNA complementary to mRNA; D, 
diversity region; ELISA, enzyme-linked immunosorbent assay; Fab 
fragments, antigen-binding fragments of Abs that are derived by papain 
digestion and contain the light chain and part ofthe heavy chain (variable 
region and first constant domain); H, heavy chain of Ab; Ig, immunoglo- 
bulin; J, joining region; kb, kilobase or 1000 bp; L, light chain of Ab; 
mAb, monoclonal Ab; nt, nucleotide(s); oligo, oligodeoxyribonucleotide; 
PA, polyacrylamide; PCR, polymerase chain reaction; ss, single 
strand(ed); c/r, untranslated region; V,,, variable heavy chain; V, , 
variable light chain. 
are now widely accepted. A major progress toward thera- 
peutic applicability was the construction of chimeric Abs 
with variable rodent and constant human domains 
(Verhoeyen and Riechmann, 1988). Substantially lower im- 
munogenicity has been found for chimeric Abs compared to 
their murine counterparts in colon cancer patients (Lo 
Buglio et al., 1989). With the advent of PCR technology 
(Saiki et al., 1985; 1988) cloning of cDNAs for L and H 
chains of Ig genes has been dramatically facilitated by 
making use of degenerate oligos (LeBceuf et al., 1989; 
Orlandi et al., 1989; Huse et al., 1989; Larrick et al., 1989). 
For expression, the V, and I’, regions have to be cloned 
into vectors carrying the appropriate constant human 
region thus mimicking Zg genes. In contrast to Ig cDNAs, 
Zg genes are well expressed in Ig nonproducer hybridoma 
cells (Weidle et al., 1987). For this purpose, the isolated V 
regions have to be mutagenized to match the reading frame 
of the 1g gene on the vector. Alternately, restriction sites 
have to be incorporated into the primers for directed cloning 
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and expression (Orlandi et al., 1989). In this paper we 
present a different approach for cloning the relevant VLJ 
and V,r>J regions with non-degenerate primers. Our tech- 
nique includes PCR amplification of specific genomic DNA 
fragments and their subsequent force-cloning into cassette 
vectors. To our knowledge, this is the first report on the 
cloning of rearranged V,_J and V,OJ regions from genomic 
DNA by PCR. In contrast to the procedure described by 
Orlandi et al. (1989), the expressed Ab gene retains its 
authentic signal peptide sequence (including introns) and 
does not differ at the N-terminal aa from the original murine 
Ab. 
EXPERIMENTAL AND DISCUSSION 
(a) Principle of the method for chimerization 
The most important prerequisite for the new method of 
chimerization is the knowledge of the exact sequence of the 
5’UT region of the mRNA and of the 3 region used for the 
V,.J and V,,DJ rearrangement for the L and H chain of the 
Ab. This information allows the design of nondegenerate 
primers for the isolation of the relevant V,J and V,,DJ 
Primer a: 5'-GATCGTCGACAAGACTCAGCCTGGACATGATGTCC 
sail '... 
. . . . . . . . . . ..*.*...... 
5'UT 
Primer b: 5'-ATCAGCGGCCGCACTTAACAAGGTTAGACTTAGTG 
Not, .."..intron.~;.'...... 
Primer c: 5'-CATAGTCGACGTTAGTCTTAAGGCACCACTGAGCC 
-............,.......*.... 
&/I 5'UT+a 
Primer d: 5'-GAGCGCGGCCGCTTAAAAATAAAGACCTGGAGAGGCCA 
. . . . . . . . . . . . . . . . . . . . . . . . . . 
Notl Intron J4-,za 
Fig. 1. Primers used for ampli~~ation of V, J and Y,,DJ regions ofm4b 
MT15 I by PCR. Primers a and b were used for amplification of the V’~ .I
region, c and d for the amplification of the V, ,DJ region of mAb MT1 5 1. 
Primers a. b and c are 35.mers, and primer d is a 3X-mer. The numbers 
of matching nt for primers a, b, E and d are 25, 23. 25 and 26. Primers 
tvere synthesized on an Applied Riosystems (Foster City, CA) oligo 
synthesizer. The 5’ primers contain in their overhanging part four nt and 
a G/I re~ognitiol~ site, the matching part corresponds to nt in the f’C’7 
region of ti and the yzl, mRNA. The 3’ primers contain in their non- 
matching part four random nt and a lYorl recognition site, in their 
matching part 23 nt corresponding to the J, intron of the L-chain 
encoding gene and to the J4 intron of the H-chain encoding gene. Restric- 
tion sites are underlined. Dashed lines represent Ig gene sequences. 
A: Liiht chain 
CAP 
Pwner 2 
1 
Noti 
PCR 
s S ‘4 Jz Light chain 
Sal I q lg promoter . Enhancer 
5’UT lntron lntron n Signal sequence H Mouse constant region 
q Variable region @ 5’ untranslated region 
q Joining region q lntr0rl 
B: Heavy chain 
CAP 
Heavy chain 
q lg promoter e Enhancer 
n Signal sequence q Exons of mouse 
q Variable ragion constant region 
q Divarsity ragion q 5’ untranslated region 
•$ Joining region 0 lntron 
Fig. 2. Schematic representation of the chimerization method. The procedure is shown for the L chain (A) and for the H chain (B). PCR amplification 
with primers complementary to the 5’UT region of the mRNA and to intron sequences 3’ to the J segment used for rearrangement leads to V, J and 
V,,DJ fragments with a .%/I site at their 5’ ends and a N<J!I site at their 3’ ends for directed cloning into cassette vectors with Ig promoter elements 
and the appropriate human constant regions. A general outline of the procedure is described in section a. C, constant region: CAP, initiation site for 
mRNA; I), diversity region; E, and E,,, enhancers for light and heavy chain; H. hinge region; J, joining region; S, signal sequence: V, and V,,, variable 
region of L and H Ig genes. 
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regions from DNA of the hybridoma cell line by PCR. The 
primers (Fig. 1) are designed as follows: (a) and (c) 5’ 
primers matching to the 5’ UT regions of L and H chain 
mRNA. They include at their 5’ end a restriction enzyme 
cleavage site (SalI) useful for force cloning. Primers (b) and 
(d) are the 3’ primers matching the intron sequences down- 
stream from the J region used for the rearrangement. This 
is possible because the J loci for the L and H chains of the 
mouse are completely sequenced (Max, 1981; Sakano 
et al., 1980). The 3’ primers include a Not1 cleavage site at 
their 5’ ends for force cloning of the amplified fragments. 
As a result of the amplification procedure promoterless I’,__! 
and V,OJ fragments are obtained including its intron, the 
V,J or V,OJ region and intron sequences 3’ from the J 
region used for rearrangement including the splice donor 
consensus GT (Fig. 2). The resulting amplified V,J and 
V,OJ fragments are endowed with a SafI site at their 5’ 
ends and a Not1 site at their 3’ ends for directed cloning into 
a cassette vector containing Ig promoter elements and ap- 
propriate human constant regions. 
(b) Application of the technique to the chimerization of an 
anti-CD4 antibody 
The mAb MT1 5 1 (IgG,,) binds to an epitope in the first 
extracellular loop of the human T lymphocyte surface anti- 
gen CD4 (Reinherz et al., 1986). The murine Ab has been 
successfully used in the treatment of patients with rheu- 
matoid arthritis (Herzog et al., 1987). Therefore, a chimer- 
ized, less immunogenic version of this Ab is of great im- 
portance for clinical applications. The sequence of the 5’ UT 
and the V regions of the K and 1/2, chains of mAb MT151 
was determined as described in the legend to Fig. 3. We 
identified rearrangement of V, with the J2 segment of the L 
chains and of V, with J4 of the H chains. This information 
enabled us to synthesize 5’ and 3’ primers for amplification 
of the rearranged VJ and VDJ segment by PCR (Fig. 1). 
For the light chain, a 600-bp V,J fragment, and for the 
heavy chain, an approx. 700-bp VDJ fragment was ampli- 
fied (Fig. 3). The fragments with Sal1 and Not1 sites were 
subcloned and the sequences of live isolates for each chain 
were determined (Sanger et al., 1977). Compared to the 
cDNA sequence we detected an exchange in one of the five 
V,J isolates as well as in one of the five V,DJ isolates due 
to the high error rate of Taq polymerase. We have applied 
the described technique to isolate the V,J and V,DJ seg- 
ments of the two additional mAbs, one directed against an 
epitope on human CD4 different from that of mAb MT 15 1 
and another binding to the cc-chain of the human interleu- 
kin-2 receptor. Also for these two mAbs fragments in the 
range of 600-700 bp were amplified (data not shown). Se- 
quencing of live isolates of subcloned V,J and V,DJ 
regions for each Ab revealed that the error rate of Taq 
polymerase was comparable to that obtained for mAb 
ABCDEFGH 
kb 
Fig. 3. Amplification of V,J and V,,DJ regions encoding mAb MT151 
by PCR. Lanes: A and H, marker fragments; B and F, control PCR 
(minus DNA); C, amplification with primers c and d; D and E, amplifica- 
tion with yprimers different from those shown in Fig. 1; G, amplification 
with K primers a and b. The sequences of primers a, b, c and d are shown 
in Fig. 1. Methods. For cDNA cloning and sequence determination RNA 
was isolated from 2 x 10’ cells (Chirgwin et al., 1979). The RNA pellet 
(250 pg) was dissolved in 12.5 ~1 H,O, incubated with 375 ~1 dimethylsul- 
foxide for 20 min at 45°C ethanol-precipitated and dissolved in H,O. 
Synthesis of cDNA was performed with 200 pg RNA and 20 ng “P- 
labelled primers with the first-strand buffer of the BRL cDNA synthesis 
kit according to the instructions ofthe manufacturer. k primer: 5’-GAA- 
GATGGATACAGTTGGTGC. y primer: 5’-GGCCAGTGGATAGA- 
CAGATGG. These primers match the 5’ part of the constant regions of 
the K and the y chain. After treatment of the ss DNA with 50 pg RNase 
A for 30 min, phenolization and ethanol precipitation, the ssDNAs were 
size-fractionated on a 5% PA gel and the position of the Vt, and I’,, 
fragments visualized by autoradiography. The bands were excised, DNA 
eluted with 2 M NH,. acetate at 37°C precipitated, and tailed with G 
residues with terminal deoxynucleotidyl-transferase (Maniatis et al., 
1982). After phenol extraction and ethanol precipitation, the ss DNA was 
dissolved in 10 ~1 H,O. 3 ~1 were used for the following PCR reaction. 
10 pmol of 5’ and 3’ oligos were used in a 20~1 reaction in 10 mM 
Tris HCl pH 8.4/50 mM KCl/l mM MgClJ0.1 mM dNTPs and Taq 
polymerase. 5’ primer: 5’-GCATGCGCGCGGGCCGCGGAGGCCC- 
CCCCCCCCCCC (contains sites for SUCH, SphI, Nor1 and SJI; Loh 
et al., 1989). The 3’ primer contains an EcoRI cleavage site near the 5’ 
end and matches the nt of the 5’ part of the constant regions of K and 
y mRNA. 3’ primer K: 5’-GGGAATTCTGGTGCAGCATCAGCCC. 
3’ primer 7: 5’-GGGAATTCGATAGACAGATGGGGGTG. The 
reaction was carried out in a Perkin-Elmer cycler with the following 
conditions: 5 min at 94°C 2 min at 42°C five cycles (1 min each) at 
72°C 1 min at 94°C 1 min at 55’C, 20 cycles at 72°C (1 min each), 
10 min at 72°C. An aliquot of the PCR products was size-fractionated 
on a 1 y0 low-melting-agarose gel, the amplified DNA was eluted, cleaved 
with EcoRI +Notl, subcloned and the sequence determined by the 
dideoxy method (Sanger et al., 1977). Reaction conditions for PCR ampli- 
fication with primers a, b, c and d: 10 mM Tris. HCI pH 8.3/50 mM 
KQl.5 mM MgCI,/O.l % (w/v) gelatine/l pg chromosomal DNA/s’ and 
3’ primer 1 ng each/dATP, dGTP, dCTP, dTTP 200 PM each/Taq poly- 
merase (Boehringer-Mannheim) 2.5 units in a reaction volume of 100 ~1. 
The reaction mixture was overlayered with 100 ~1 mineral oil (Sigma). 
The reaction mixture was kept at 92°C for 5 min, then for 2 min at 55°C 
and 2 min at 72°C. Before the following 26 cycles at 72°C (2 min each) 
the mixture was kept for 2 min at the temperatures indicated above. 10% 
of the mix was size-fractionated on a 1.5 y0 low-melting-point agarose gel 
(0.5 ng ethidium bromide/ml), the amplified DNA was isolated, cleaved 
with Sal1 + Not1 and ethanol-precipitated. 
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AP 
human intron K 
pUHWK: 
1 3’UT 
u40, 
B Sal I 
Kpnl ,I,,, Not1 
mouse intron 
heavy chain 
pUHW),i 
CHz 
C ~‘1 (human) 
Fig. 4. Expression vectors for chimeric Ab in non-Ig producer hybridoma 
cells. Amplified V,J and VHDJ fragments encoding mAb MT15 1 (Fig. 3) 
were cloned as SalI-Not1 fragments into cassette vectors pUHW ti (A), 
and pUHWy1 (B) (which were cleaved with Sal1 +NotI) to give rise to 
vectors pUHW-CD~K and pUHW-CD4yl by forced cloning. As pro- 
moter elements both vectors contain a combination of a heavy-chain 
enhancer (E,,), and a p gene promoter (PPr) (Weidle et al., 1987). Both 
vectors contain a polylinker including unique KpnI, Sal1 and Not1 sites. 
Plasmid ~UHWK contains the constant region of a human K gene and is 
based on pSV2neo (Southern and Berg, 1982). The plasmid contains a 
hybrid light-chain intron with mouse and human elements. Plasmid 
~UHWK contains the mouse light-chain enhancer region as a 2-kb 
EcoRI-Asp700 fragment (Picard and Schaffner, 1984) and a part of the 
human light chain intron, the human K exon and 3’ (iTregion as a 2.8-kb 
fragment from pC1 (Klobeck et al., 1984). Plasmid pUHWy1 is the 
cassette vector for the insertion of amplified V,,DJ fragments. It contains 
the mouse heavy-chain enhancer region as a 1.6-kb HindIII-EcoRI frag- 
ment (Neuberger. 1983) and part of the human heavy-chain intron, the 
four exons and three introns and 3’ UT region of the human ~1 gene as 
a 7-kb Hind111 fragment (Takahashi et al., 1984). Plasmids pUHW- 
CD~K and pUHW-CD4yl were linearized at their unique PvuI sites and 
an equimolar mixture ofboth plasmids (5 pg per 10h cells) was transfected 
into Sp2iO cells (Ochi et al., 1983) by electroporation. Stable transfec- 
tants were isolated by selection with G418 (1000 pgjml) as described 
(Lenz and Weidle, 1990) and reconstituted Ab was quantified by ELISA. 
PPr, promoter of a mouse /.I gene; E, and E,,, enhancers of light and 
heavy chains of the mouse. respectively: 3’ UT, 3’ untranslated region; 
MT151. The size of the intron which separates the signal 
sequences was in the range between 60 and 120 nt, when the 
six isolates of the three mAbs were compared (data not 
shown). All three mAbs make use of different J segments. 
From these observations we conclude that the method is of 
general applicability. After sequencing, the amplified S&I- 
Not1 fragments (V,J and V’,OJ) of mAb MT151 were 
force-cloned into cassette vectors ~UHWK- (with a human 
K constant region) and pUHWyl (with a human ~1 con- 
stant region). The vectors are displayed in Fig. 4. Both 
vectors make use of heavy-chain enhancer and promoter 
elements at the 5’ end of the V,,J and V, DJ fragments to 
be inserted by force-cloning and can be linearized at their 
unique Paul sites in the ApK gene before transfection 
into hybridoma cells. Plasmids ~UHWICCD~ and 
pUHWyCD4 obtained after ligation of the appropriate V,J 
and V,DJ fragments into ~UHWK and pUHWy1 were 
transfected into Sp2/0 cells (Ochi et al., 1983) and stable 
transformants were isolated by G418 selection. Transfor- 
mants expressing up to 10 pg/ml of chimerized Ab per 10h 
cells and 24 h were obtained. 
(c) Conclusions 
(I) We demonstrated for the first time the feasibility of 
cloning rearranged genomic V,J and V,DJ segments of Ab 
with PCR and nondegenerate oligos. 
(2) After the PCR, the amplified promoterless frag- 
ments can be directionally cloned into cassette vectors 
carrying the appropriate human constant regions. 
(3) The method seems to be of general applicability 
because it has been applied successfully to the chimeri- 
zation of Ab from three different hybridoma cell lines. 
(4) Contrary to previous approaches making use of 
cDNA cloning, mutation and insertion into expression vec- 
tors, authentic V,J and V,DJ genomic segments are 
isolated by our method. 
(5) High-level synthesis of chimerized Ab was moni- 
tored after transfection of expression vectors with human K 
and yl constant regions and the V,J and V,DJ regions of 
the murine Ab into non-Ig-producer myeloma cells. 
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